Cortexyme CRTX

$ 1.88 -1.05%

Quarterly report 2024-Q3
added 11-13-2024

Cortexyme Financial Statements 2011-2024 | CRTX

Annual Financial Statements Cortexyme

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	70 M	63 M	181 M	1.16 B	988 M	-	-	-	-	-	-	-	-
Shares	37.2 M	33.5 M	29.7 M	29.5 M	19.1 M	-	-	-	-	-	-	-	-
Historical Prices	1.88	1.88	6.08	39.2	47	-	-	-	-	-	-	-	-
Net Income	-31.4 M	-51.7 M	-89.9 M	-76.8 M	-37 M	-12.5 M	-12.2 M	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-34.6 M	-52 M	-90.3 M	-78.9 M	-39.2 M	-12.1 M	-	-	-	-	-	-	-
Interest Expense	-102 K	-997 K	-247 K	-	-	957 K	-	-	-	-	-	-	-
EBITDA	-34.3 M	-51.8 M	-90 M	-76.5 M	-39 M	-11.3 M	-10.3 M	-	-	-	-	-	-
Operating Expenses	34.6 M	52 M	90.3 M	78.9 M	39.2 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	17.7 M	26 M	29.5 M	17.6 M	8.95 M	2.03 M	1.27 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Cortexyme

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	43.2 M	43.1 M	43 M	43 M	36.1 M	35.9 M	35.9 M	36.1 M	35.6 M	32.5 M	30.1 M	30.1 M	29.8 M	29.6 M	29.6 M	29.5 M	29.5 M	29.4 M	28.3 M	26.9 M	26.8 M	15.8 M	3.52 M	3.41 M	3.36 M	3.36 M	3.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-5.49 M	-27.7 M	-11.1 M	-	-5.35 M	-4.89 M	-12.3 M	-	-7.92 M	-16.6 M	-21.6 M	-	-21.7 M	-21.8 M	-23.1 M	-	-21.5 M	-17.6 M	-17.2 M	-	-9.86 M	-9.06 M	-5.68 M	-	-2.52 M	-3.11 M	-3.38 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-5.86 M	-28.2 M	-11.2 M	-	-6.09 M	-5.58 M	-13 M	-	-7.62 M	-16.3 M	-21.9 M	-	-21.7 M	-21.8 M	-23.3 M	-	-21.9 M	-18.3 M	-17.9 M	-	-10.6 M	-9.58 M	-6.08 M	-	-2.87 M	-2.64 M	-2.76 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	150 K	91 K	-399 K	-	-216 K	-107 K	-246 K	-	-616 K	-735 K	150 K	-	-157 K	-131 K	-	-	-	-	-	-	-	-	-	-	957 K	358 K	599 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-11.2 M	-	-	-	-12.9 M	-	-7.46 M	-16.1 M	-21.8 M	-	-21.4 M	-21.6 M	-23.2 M	-	-21.7 M	-18.1 M	-17.8 M	-	-10.5 M	-9.52 M	-6.06 M	-	-2.85 M	-2.63 M	-2.75 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	5.86 M	28.2 M	11.2 M	-	6.09 M	5.58 M	13 M	-	7.62 M	16.3 M	21.9 M	-	21.7 M	21.8 M	23.3 M	-	21.9 M	18.3 M	17.9 M	-	10.6 M	9.58 M	6.08 M	-	2.87 M	2.64 M	2.76 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.63 M	4.7 M	4.97 M	-	4.66 M	4.23 M	3.83 M	-	4.34 M	9.06 M	9.11 M	-	7.64 M	7.06 M	6.49 M	-	4.93 M	4.18 M	3.48 M	-	2.32 M	2.47 M	1.25 M	-	584 K	357 K	347 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency